Hemostemix Inc.

C$0.05As of Sun 8 Nov 2026, 12:00 UTC
TSXV:HEMHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (33.97%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.71
PE TTM —
TSR TTM (50.00%)
Mkt cap C$10.57M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.06
20.05%
26.83%
Hold 12|12|9|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
17.66%
11.14%
14.29%
20.11%
Revenue$M
0.881
0.898
0.926
0.901
10.36%
12.36%
14.20%
7.90%
Peers (US$7.483M)
Cap (US$)
PE
8.155M
0.687x
7.338M
—
Capital
TTM
5Y
10Y
Leveragex
0.190
1.476
1.471
EBIT/Intx
1.027
0.088
0.091
Own earn%
(53.37)
284.80
235.68
Sh yield%
34.54
22.73
28.48
Owners
Insiders/Inst%
3.34
54.35
Short interest%
3.48
SBC / revenue%
2.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
22–29
$1 testx
—
Incr. ROIC%
7